What is Immunovant, Inc.'s stock issuance proceeds?

Immunovant, Inc. (IMVT) reported stock issuance proceeds of $0 in Q1 2026.

How has Immunovant, Inc.'s stock issuance proceeds changed year-over-year?

Immunovant, Inc.'s stock issuance proceeds decreased by 100.0% year-over-year, from $450M to $0.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Immunovant, Inc. IMVT Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

ImmunityBio, Inc.IBRX

$971K+341%

Summit TherapeuticsSMMT

$3.8M+88.1%

TG TherapeuticsTGTX

$763K+3,533%

Roivant SciencesROIV

-$217.17M—

Apogee Therapeutics, Inc.APGE

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Net income-$147.9M-38.9%

EPS (diluted)-$0.73-15.9%

Balance sheet

See full

Cash & equivalents$902.1M+26.4%

Total debt$72.0K-26.5%

Total equity$852.6M+20.5%

Total assets$957.0M+23.3%

Cash flow

See full

Operating cash flow-$95.1M+14.1%

CapEx$8.0K-96.0%

Free cash flow-$95.1M+14.2%

Valuation

See full

Market cap$7.26B+74.2%

Enterprise value$6.35B+89.7%

Returns & leverage

See full

Return on equity-64.8%+2.5pp

Debt / equity0×0.0×

Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunovant, Inc.'s stock issuance proceeds?: Immunovant, Inc. (IMVT) reported stock issuance proceeds of $0 in Q1 2026.
How has Immunovant, Inc.'s stock issuance proceeds changed year-over-year?: Immunovant, Inc.'s stock issuance proceeds decreased by 100.0% year-over-year, from $450M to $0.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.